Radiological evaluation, management, and surveillance of renal masses in Von Hippel-Lindau disease

Clinical Radiology

Volumn 64, Issue 6, 2009, Pages 589-600

  Meister, M ^a   Choyke, P ^b   Anderson, C ^a   Patel, U ^a  

^a ST GEORGE S HOSPITAL   (United Kingdom)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER EPIDEMIOLOGY; CANCER GENETICS; CANCER SCREENING; CLINICAL EVALUATION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; HUMAN; KIDNEY CARCINOMA; KIDNEY TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIODIAGNOSIS; RECURRENT CANCER; RENOGRAPHY; REVIEW; ULTRASOUND; VON HIPPEL LINDAU DISEASE;

ADULT; CARCINOMA, RENAL CELL; CONTRAST MEDIA; CYSTS; HUMANS; KIDNEY DISEASES; KIDNEY NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; TOMOGRAPHY, X-RAY COMPUTED; UBIQUITIN-PROTEIN LIGASES; ULTRASONOGRAPHY; VON HIPPEL-LINDAU DISEASE; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 67349284671     PISSN: 00099260     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.crad.2008.10.010     Document Type: Review

References (53)

1. Richard S., Graff J., Llndau J., and Resche F. Von Hippel-Lindau disease. Lancet 363 (2004) 1231-1234
2. Latif F., Tory K., Gnarra J., et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 260 (1993) 1317-1320
3. Maher E.R. Von Hippel-Lindau disease. Curr Mol Med 4 (2004) 833-842
4. Pavlovich C.P., and Schmidt L.S. Searching for the hereditary causes of renal-cell carcinoma. Nat Rev Cancer 4 (2004) 381-393
5. Banks R.E., Tirukonda P., Taylor C., et al. Genetic and epigenetic analysis of von Hippel-Lindau (VHL) gene alterations and relationship with clinical variables in sporadic renal cancer. Cancer Res 66 (2006) 2000-2011
6. http://info.cancerresearchuk.org/cancerstats/types/kidney/incidence/. (accessed 12 January 2008)
7. Chow W.H., Devesa S.S., Warren J.L., and Fraumeni Jr. J.F. Rising incidence of renal cell cancer in the United States. JAMA 281 (1999) 1628-1631
8. Patard J.J., Rodriguez A., Rioux-Leclercq N., et al. Prognostic significance of the mode of detection in renal tumours. BJU Int 90 (2002) 358-363
9. Tsui K.H., Shvarts O., Smith R.B., et al. Renal cell carcinoma: prognostic significance of incidentally detected tumors. J Urol 163 (2000) 426-430
10. Choyke P.L., Glenn G.M., Walther M.M., et al. Hereditary renal cancers. Radiology 226 (2003) 33-46
11. Linehan W.M., Walther M.M., and Zbar B. The genetic basis of cancer of the kidney. J Urol 170 (2003) 2163-2172
12. Pischon T., Lahmann P.H., Boeing H., et al. Body size and risk of renal cell carcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer 118 (2006) 728-738
13. Ong K.R., Woodward E.R., Killick P., et al. Genotype-phenotype correlations in von Hippel-Lindau disease. Hum Mutat 28 (2007) 143-149
14. Hes F.J., and Feldberg M.A. Von Hippel-Lindau disease: strategies in early detection (renal-, adrenal-, pancreatic masses). Eur Radiol 9 (1999) 598-610
15. Knudson Jr. A.G. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 68 (1971) 820-823
16. Zbar B., Kishida T., Chen F., et al. Germline mutations in the Von Hippel-Lindau disease (VHL) gene in families from North America, Europe, and Japan. Hum Mutat 8 (1996) 348-357
17. Kim W.Y., and Kaelin W.G. Role of VHL gene mutation in human cancer. J Clin Oncol 22 (2004) 4991-5004
18. Lonser R.R., Glenn G.M., Walther M., et al. von Hippel-Lindau disease. Lancet 361 (2003) 2059-2067
19. Poston C.D., Jaffe G.S., Lubensky I.A., et al. Characterization of the renal pathology of a familial form of renal cell carcinoma associated with von Hippel-Lindau disease: clinical and molecular genetic implications. J Urol 153 (1995) 22-26
20. Walther M.M., Lubensky I.A., Venzon D., et al. Prevalence of microscopic lesions in grossly normal renal parenchyma from patients with von Hippel-Lindau disease, sporadic renal cell carcinoma and no renal disease: clinical implications. J Urol 154 (1995) 2010-2014 discussion 2014-5
21. Neumann H.P., Bender B.U., Berger D.P., et al. Prevalence, morphology and biology of renal cell carcinoma in von Hippel-Lindau disease compared to sporadic renal cell carcinoma. J Urol 160 (1998) 1248-1254
22. Maher E.R., YAtes J.R., Harries R., et al. Clinical features and natural history of von Hippel-Lindau disease. Q J Med 77 (1990) 1151-1163
23. Choyke P.L., Glenn G.M., Walther M.M., et al. von Hippel-Lindau disease: genetic, clinical, and imaging features. Radiology 194 (1995) 629-642
24. Leung R.S., Biswas S.V., Duncan M., and Rankin S. Imaging features of von Hippel-Lindau disease. RadioGraphics 28 (2008) 65-79 quiz 323
25. Bosniak M.A. The current radiological approach to renal cysts. Radiology 158 (1986) 1-10
26. Israel G.M., Hindman N., and Bosniak M.A. Evaluation of cystic renal masses: comparison of CT and MR imaging by using the Bosniak classification system. Radiology 231 (2004) 365-371
27. Israel G.M., and Bosniak M.A. Follow-up CT of moderately complex cystic lesions of the kidney (Bosniak category IIF). AJR Am J Roentgenol 181 (2003) 627-633
28. Curry N.S., Cochran S.T., and Bissada N.K. Cystic renal masses: accurate Bosniak classification requires adequate renal CT. AJR Am J Roentgenol 175 (2000) 339-342
29. Harisinghani M.G., Maher M.M., Gervais D.A., et al. Incidence of malignancy in complex cystic renal masses (Bosniak category III): should imaging-guided biopsy precede surgery?. AJR Am J Roentgenol 180 (2003) 755-758
30. Bosniak M.A. Should we biopsy complex cystic renal masses (Bosniak category III)?. AJR Am J Roentgenol 181 (2003) 1425-1426 author reply 1426
31. Israel G.M., and Bosniak M.A. How I do it: evaluating renal masses. Radiology 236 (2005) 441-450
32. Claudon M., Cosgrove D., Albrecht T., et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) - update 2008. Ultraschall Med 29 (2008) 28-44
33. Ascenti G., Mazzioti S., Zimbaro G., et al. Complex cystic renal masses: characterization with contrast-enhanced US. Radiology 243 (2007) 158-165
34. Cohan R.H., Sherman L.S., Korbkin M., et al. Renal masses: assessment of corticomedullary-phase and nephrographic-phase CT scans. Radiology 196 (1995) 445-451
35. Beer A.J., Dobritz M., Zantl N., et al. Comparison of 16-MDCT and MRI for characterization of kidney lesions. AJR Am J Roentgenol 186 (2006) 1639-1650
36. Tattersall D.J., and Moore N.R. von Hippel-Lindau disease: MRI of abdominal manifestations. Clin Radiol 57 (2002) 85-92
37. Semelka R.C., Cumming M.J., Shoenut J.P., et al. Islet cell tumors: comparison of dynamic contrast-enhanced CT and MR imaging with dynamic gadolinium enhancement and fat suppression. Radiology 186 (1993) 799-802
38. Lauenstein T.C., Salman K., Morreira R., et al. Nephrogenic systemic fibrosis: center case review. J Magn Reson Imaging 26 (2007) 1198-1203
39. Walter C., Kruessell M., Gindele A., et al. Imaging of renal lesions: evaluation of fast MRI and helical CT. Br J Radiol 76 (2003) 696-703
40. Walther M.M., Choyke P.L., Glenn G., et al. Renal cancer in families with hereditary renal cancer: prospective analysis of a tumor size threshold for renal parenchymal sparing surgery. J Urol 161 (1999) 1475-1479
41. Richard S. von Hippel-Lindau disease: recent advances and therapeutic perspectives. Expert Rev Anticancer Ther 3 (2003) 215-233
42. Grubb III R.L., Choyke P.L., Pinto P.A., et al. Management of von Hippel-Lindau-associated kidney cancer. Nat Clin Pract Urol 2 (2005) 248-255
43. Duffey B.G., Choyke P.L., Glenn G., et al. The relationship between renal tumor size and metastases in patients with von Hippel-Lindau disease. J Urol 172 (2004) 63-65
44. Goldfarb D.A., Neumann H.P., Penn I., and Novick A.C. Results of renal transplantation in patients with renal cell carcinoma and von Hippel-Lindau disease. Transplantation 64 (1997) 1726-1729
45. Choyke P.L., and Daryanani K. Intraoperative ultrasound of the kidney. Ultrasound Q 17 (2001) 245-253
46. Herring J.C., Enquist E.G., Chernoff A., et al. Parenchymal sparing surgery in patients with hereditary renal cell carcinoma: 10-year experience. J Urol 165 (2001) 777-781
47. Shingleton W.B., and Sewell Jr. P.E. Percutaneous renal cryoablation of renal tumors in patients with von Hippel-Lindau disease. J Urol 167 (2002) 1268-1270
48. Gervais D.A., McGovern F.J., Arellano R.S., et al. Renal cell carcinoma: clinical experience and technical success with radio-frequency ablation of 42 tumors. Radiology 226 (2003) 417-424
49. Su L.M., Jarrett T.W., Chan D.Y., et al. Percutaneous computed tomography-guided radiofrequency ablation of renal masses in high surgical risk patients: preliminary results. Urology 61 Suppl. 1 (2003) 26-33
50. Kaelin Jr. W.G. Molecular basis of the VHL hereditary cancer syndrome. Nat Rev Cancer 2 (2002) 673-682
51. Richards R.D., Mebust W.K., and Schimke R.N. A prospective study on Von Hippel-Lindau disease. J Urol 110 (1973) 27-30
52. Lee K.R., Wulfsberg E., and Kepes J.J. Some important radiological aspects of the kidney in von Hippel-Lindau syndrome: the value of prospective study in an affected family. Radiology 122 (1977) 649-653
53. Filling-Katz M.R., et al. Radiologic screening for von Hippel-Lindau disease: the role of Gd-DTPA enhanced MR imaging of the CNS. J Comput Assist Tomogr 13 (1989) 743-755